Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women (Q24629582)

Tanuja N Gengiah

11

0 references

Koleka Mlisana

Koleka P Mlisana

9

0 references

Salim Abdool Karim

Salim S Abdool Karim

2

0 references

Anneke C. Grobler

Anneke C Grobler

4

0 references

Cheryl Baxter

5

Cheryl Baxter

0 references

Lynn Morris

15

Lynn Morris

0 references

Sengeziwe Sibeko

8

Sengeziwe Sibeko

0 references

author name string

Janet A Frohlich

3

0 references

Leila E Mansoor

6

0 references

Ayesha B M Kharsany

7

0 references

Zaheen Omar

10

0 references

Silvia Maarschalk

12

0 references

Natasha Arulappan

13

0 references

Mukelisiwe Mlotshwa

14

0 references

Douglas Taylor

on focus list of Wikimedia project

16

0 references

language of work or name

English

0 references

publication date

3 September 2010

0 references

published in

Science

0 references

volume

329

0 references

page(s)

1168-74

0 references

issue

5996

0 references

ScienceSource

0 references

cites work

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Prediction of creatinine clearance from serum creatinine

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Toward an information-motivation-behavioral skills model of microbicide adherence in clinical trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Screening for 'window-period' acute HIV infection among pregnant women in rural South Africa

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Uptake of provider-initiated HIV testing and counseling among women attending an urban sexually transmitted disease clinic in South Africa - missed opportunities for early diagnosis of HIV infection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Weighing the gold in the gold standard: challenges in HIV prevention research

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Risk compensation: the Achilles' heel of innovations in HIV prevention?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.

30 May 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1193748

Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1193748

The evolving HIV epidemic in South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1193748

Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1193748

Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1193748

Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001187

In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20643915

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

HIV prevention: the need for methods women can use

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20643915

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1126/SCIENCE.1193748

1 reference

178830

178830

1 reference

1 reference

1 reference